This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Dec;58(6):836-7.

doi: 10.1016/j.eururo.2010.09.003. Epub 2010 Sep 15.

Further support for active surveillance in the management of low-volume, low-grade prostate cancer

Peter Albertsen

PMID: 20851512
DOI: 10.1016/j.eururo.2010.09.003

Editorial

Further support for active surveillance in the management of low-volume, low-grade prostate cancer

Peter Albertsen. Eur Urol. 2010 Dec.

. 2010 Dec;58(6):836-7.

doi: 10.1016/j.eururo.2010.09.003. Epub 2010 Sep 15.

Author

Peter Albertsen

PMID: 20851512
DOI: 10.1016/j.eururo.2010.09.003

No abstract available

PubMed Disclaimer

Comment on

Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.
Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M. Soloway MS, et al. Eur Urol. 2010 Dec;58(6):831-5. doi: 10.1016/j.eururo.2010.08.027. Epub 2010 Aug 20. Eur Urol. 2010. PMID: 20800964

Similar articles

Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.
Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M. Soloway MS, et al. Eur Urol. 2010 Dec;58(6):831-5. doi: 10.1016/j.eururo.2010.08.027. Epub 2010 Aug 20. Eur Urol. 2010. PMID: 20800964
Editorial comment on: tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
Gallina A. Gallina A. Eur Urol. 2010 Apr;57(4):639. doi: 10.1016/j.eururo.2009.03.008. Epub 2009 Mar 10. Eur Urol. 2010. PMID: 19299073 No abstract available.
Editorial comment on: tumor grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
Yossepowitch O. Yossepowitch O. Eur Urol. 2010 Apr;57(4):639-40. doi: 10.1016/j.eururo.2009.03.009. Epub 2009 Mar 10. Eur Urol. 2010. PMID: 19299071 No abstract available.
Endocrine treatment: expected duration stage by stage.
Schröder FH. Schröder FH. Prostate Suppl. 2000;10:26-31. Prostate Suppl. 2000. PMID: 11056490 Review. No abstract available.
Economic analysis of active surveillance for localized prostate cancer.
Kim S 2nd, Dall'Era MA, Evans CP. Kim S 2nd, et al. Curr Opin Urol. 2012 May;22(3):247-53. doi: 10.1097/MOU.0b013e328351dd32. Curr Opin Urol. 2012. PMID: 22388666 Review.

See all similar articles

Cited by

Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer.
Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA. Yerram NK, et al. BJU Int. 2012 Dec;110(11 Pt B):E783-8. doi: 10.1111/j.1464-410X.2012.11646.x. Epub 2012 Nov 6. BJU Int. 2012. PMID: 23130821 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information